148
Journals
668.9K
Articles
12.3M
Citations
108.5K
Authors

Most Cited Articles of Hematology in 2013

TitleJournalYearCitations
Cancer statistics, 2013Ca-A Cancer Journal for Clinicians201310.3K
Investigation of the freely available easy-to-use software 'EZR' for medical statisticsBone Marrow Transplantation20137.5K
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology20132K
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Blood20131.4K
Guidelines for the management of hemophiliaHaemophilia20131.2K
Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood20131.2K
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerCritical Reviews in Oncology/Hematology2013827
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaBlood2013750
Epidemiology of cancer-associated venous thrombosisBlood2013634
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)Annals of Oncology2013633
Recent progress in pancreatic cancerCa-A Cancer Journal for Clinicians2013606
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC studyAnnals of Oncology2013598
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013580
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosisStem Cells and Development2013554
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesBlood2013539
NETosis: how vital is it?Blood2013534
Mutations and prognosis in primary myelofibrosisLeukemia2013520
Immune responses to AAV vectors: overcoming barriers to successful gene therapyBlood2013519
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyBlood2013519
Potent inhibition of DOT1L as treatment of MLL-fusion leukemiaBlood2013504
Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulationThrombosis Research2013501
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cellsStem Cells and Development2013484
Umbilical cord blood transplantation: the first 25 years and beyondBlood2013480
American Cancer Society lung cancer screening guidelinesCa-A Cancer Journal for Clinicians2013475
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium ProgramBlood2013473